![Stuart Gunzburg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Gunzburg
Hoofd Techniek/Wetenschap/O&O bij
EVE HEALTH GROUP LIMITED
Vermogen: 455 300 $ op 31-05-2026
Profiel
Stuart Gunzburg is the founder of Nextract Pty Ltd. Dr. Gunzburg is currently Managing Director & Director at Metavone Ltd. Dr. Gunzburg is also Executive Director & Chief Scientific Officer at EVE Health Group Ltd., starting in 2025.
Dr. Gunzburg holds an MBA and a doctorate from The University of Western Australia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-03-2026 | 27.510.581 ( 7,81% ) | 455 300 $ | 31-05-2026 |
Actieve functies van Stuart Gunzburg
| Bedrijven | Functie | Begin |
|---|---|---|
| EVE HEALTH GROUP LIMITED | Hoofd Techniek/Wetenschap/O&O | 12-06-2025 |
Metavone Ltd.
 Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Algemeen Directeur | - |
Opleiding van Stuart Gunzburg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
EVE Health Group Ltd.
 EVE Health Group Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and retails health and wellness food products | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metavone Ltd.
Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Health Technology |
